Number of dementia sufferers in Europe between the years 2000 and 2050
暂无分享,去创建一个
R. Alexandrowicz | J. Wancata | M. Krautgartner | M. Musalek | Johannes Wancata | M Musalek | R Alexandrowicz | M Krautgartner
[1] W. McDonald,et al. Inverse association of anti‐inflammatory treatments and Alzheimer's disease , 1994, Neurology.
[2] J. Bond,et al. Costs of dementia in England and Wales in the 21st century , 2001, British Journal of Psychiatry.
[3] L. Corder,et al. Cost of illness due to dementia in Sweden , 1997, International journal of geriatric psychiatry.
[4] L. Beckett,et al. Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 , 2001, Alzheimer disease and associated disorders.
[5] Sube Banerjee,et al. EUROCARE: a cross‐national study of co‐resident spouse carers for people with Alzheimer's disease: I—factors associated with carer burden , 1999, International journal of geriatric psychiatry.
[6] V. Henderson,et al. Estrogen replacement therapy and risk of Alzheimer disease. , 1996, Archives of internal medicine.
[7] A. Hofman,et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[8] A. Hofman,et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[9] H. Bickel,et al. Demenzsyndrom und Alzheimer Krankheit: Eine Schätzung des Krankenbestandes und der jährlichen Neuerkrankungen in Deutschland , 2000 .
[10] A. Korten,et al. The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.
[11] P. Robert,et al. Clinical management of agitation in the elderly with tiapride , 2001, European Psychiatry.
[12] A Hofman,et al. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. , 1991, International journal of epidemiology.
[13] A. Hofman,et al. Rates and risk factors for dementia and Alzheimer’s disease , 1999, Neurology.
[14] D. Jolley,et al. Cost benefits of a medically supervised day treatment program for patients with Alzheimer's disease and other forms of dementia , 1989 .
[15] K. Hall,et al. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. , 1998, Archives of general psychiatry.
[16] V Hachinski,et al. The effect of different diagnostic criteria on the prevalence of dementia. , 1997, The New England journal of medicine.
[17] M. Prince. The need for research on dementia in developing countries , 1997, Tropical medicine & international health : TM & IH.
[18] B. Reisberg,et al. Addition of a frequency-weighted score to the Behavioral Pathology in Alzheimer’s Disease Rating Scale: the BEHAVE-AD-FW: methodology and reliability , 2001, European Psychiatry.
[19] A. Hofman,et al. Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980–1990 prevalence findings , 1991, Annals of neurology.
[20] D. Kildea,et al. Is senile dementia "age-related" or "ageing-related"? —evidence from meta-analysis of dementia prevalence in the oldest old , 1995, The Lancet.